Nutrients,
Journal Year:
2023,
Volume and Issue:
15(6), P. 1359 - 1359
Published: March 10, 2023
The
beneficial
effects
of
L-carnitine
on
non-alcoholic
fatty
liver
disease
(NAFLD)
were
revealed
in
previous
reports.
However,
the
underlying
mechanisms
remain
unclear.
In
this
study,
we
established
a
high
fat
diet
(HFD)-induced
NAFLD
mice
model
and
systematically
explored
dietary
supplementation
(0.2%
to
4%)
NAFLD.
A
lipidomics
approach
was
conducted
identify
specific
lipid
species
involved
ameliorative
roles
Compared
with
normal
control
group,
body
weight,
concentrations
TG
serum
AST
ALT
levels
dramatically
increased
by
HFD
feeding
(p
<
0.05),
accompanied
obvious
damage
activation
hepatic
TLR4/NF-κB/NLRP3
inflammatory
pathway.
treatment
significantly
improved
these
phenomena
exhibited
clear
dose-response
relationship.
results
analysis
showed
that
total
12
classes
145
identified
livers.
Serious
disorders
profiles
noticed
livers
HFD-fed
mice,
such
as
an
relative
abundance
decreased
PC,
PE,
PI,
LPC,
LPE,
Cer
SM
0.05).
contents
PC
PI
DG
after
4%
intervention
Moreover,
47
important
differential
notably
separated
experimental
groups
based
VIP
≥
1
p
0.05.
pathway
inhibited
glycerolipid
metabolism
activated
pathways
alpha-linolenic
acid
metabolism,
glycerophospholipid
sphingolipid
Glycosylphosphatidylinositol
(GPI)-anchor
biosynthesis.
This
study
provides
novel
insights
into
attenuating
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
14
Published: Jan. 9, 2024
Introduction
Osteoporosis,
one
of
the
most
common
non-communicable
human
diseases
worldwide,
is
prevalent
disease
adult
skeleton.
Glucocorticoid-induced
osteoporosis(GIOP)
foremost
form
secondary
osteoporosis,
extensively
researched
due
to
its
prevalence.Probiotics
constitute
a
primary
bioactive
component
within
numerous
foods,
offering
promise
as
potential
biological
intervention
for
preventing
and
treating
osteoporosis.
This
study
aimed
evaluate
beneficial
effects
probiotic
Lactobacillus
plantarum
on
bone
health
underlying
mechanisms
in
rat
model
glucocorticoid
dexamethasone-induced
using
osteoporosis
treatment
drug
alendronate
reference.
Methods
We
examined
microstructure
(Micro-CT
HE
staining)
analyzed
gut
microbiome
serum
metabolome
rats.
Results
discussion
The
results
revealed
that
L.
significantly
restored
parameters
microstructure,
with
elevated
density,
increased
number
thickness
trabeculae,
decreased
Tb.Sp.
Gut
microbiota
sequencing
showed
microbial
diversity
ratio
Firmicutes
Bacteroidota
decreased.
Beneficial
bacteria
abundance
was
(
Lachnospiraceae
_NK4A136_group,
Ruminococcus
,
UCG_005
Romboutsia
Christensenellaceae
_R_7_group),
harmful
Desulfovibrionaceae
).
According
metabolomics,
significant
changes
metabolites
occurred
different
groups.
These
differential
were
predominantly
enriched
pathways
Pentose
Glucuronate
Interconversions,
well
Propanoate
Metabolism.
Furthermore,
levels
Pyrazine
gamma-Glutamylcysteine,
which
associated
inhibition
osteoclast
formation
promoting
osteoblast
formation.
can
protect
rats
from
DEX-induced
GIOP
by
mediating
“gut
microbial-bone
axis”
production
metabolites.
Therefore
candidate
GIOP.
Redox Biology,
Journal Year:
2023,
Volume and Issue:
67, P. 102889 - 102889
Published: Sept. 19, 2023
Maternal
diets
during
pregnancy
and
lactation
are
key
determinants
that
regulate
the
development
of
metabolic
syndrome
(MetS)
in
offspring.
l-malic
acid
(MA)
was
previously
reported
to
improve
antioxidant
capacity
aerobic
metabolism.
However,
effects
maternal
MA
consumption
on
features
offspring
remain
largely
unexplored.
Herein,
through
pig
models
consuming
MA-enriched
late
lactation,
we
found
potentiated
anti-inflammatory
sows,
thereby
improving
their
reproductive
performance
growth
piglets.
also
induced
a
transition
slow-twitch
fast-twitch
fibers
early
life
Along
with
muscle
fiber-type
transition,
insulin
sensitivity
glucose
metabolism,
including
metabolism
glycolysis,
were
improved
skeletal
An
untargeted
metabolomic
analysis
further
revealed
contribution
modified
amino
Mechanistically,
remodeled
colonic
microbiota
Briefly,
abundance
Colidextribacter,
Romboutsia,
Family_XIII_AD3011_group
increased,
which
positively
associated
muscles.
A
decreased
Prevotella,
Blautia,
Prevotellaceae_NK3B31_group,
Collinsella
detected,
involved
less
sensitivity.
Notably,
milk
metabolites,
such
as
ascorbic
(AA)
granisetron
(GS),
effectors
regulating
gut
composition
The
properties
AA
GS
alleviating
resistance,
inflammation,
oxidative
stress
verified
mice
treated
high-fat
diets.
Overall,
this
study
could
modulate
inflammatory
response,
capacity,
by
vertical
transmission
metabolites.
These
findings
suggest
potential
prevention
treatment
MetS
life.
Heliyon,
Journal Year:
2024,
Volume and Issue:
10(5), P. e26991 - e26991
Published: Feb. 27, 2024
Nonalcoholic
fatty
liver
disease
(NAFLD)
is
a
stress-induced
injury
related
to
heredity,
environmental
exposure
and
the
gut
microbiome
metabolism.
Short-chain
acids
(SCFAs),
metabolites
of
microbiota
(GM),
participate
in
regulation
hepatic
steatosis
inflammation
through
gut-liver
axis,
which
play
an
important
role
alleviation
NAFLD.
However,
little
progress
has
been
made
systematically
elucidating
mechanism
how
SCFAs
improve
NAFLD,
especially
epigenetic
mechanisms
potential
therapeutic
application
as
clinical
treatment
for
Herein,
we
adopted
PubMed
Medline
search
relevant
keywords
such
'SCFAs',
'NAFLD',
'gut
microbiota',
'Epigenetic',
'diet',
'prebiotic
effect'
review
latest
research
on
NAFLD
up
November
2023.
In
this
review,
firstly,
specifically
discussed
production
function
SCFAs,
well
their
crosstalk
coordination
axis.
Secondly,
provided
updated
summary
intensive
discussion
affect
alleviate
from
perspective
genetic
epigenetic.
Thirdly,
paid
attention
pharmacological
physiological
characteristics
proposed
promising
future
direction
adopt
alone
or
combination
with
prebiotics
drugs
prevent
treat
Together,
aimed
elucidate
provide
new
insights
prospects
target
Biomedicine & Pharmacotherapy,
Journal Year:
2024,
Volume and Issue:
178, P. 117156 - 117156
Published: July 19, 2024
Gut
microbiota
acts
as
a
critical
regulator
in
the
development
of
nonalcoholic
fatty
liver
disease
(NAFLD),
making
probiotics
promise
therapeutic
strategy.
Studies
are
needed
to
identify
beneficial
Bacteroides
strains
against
NAFLD.
ovatus
(B.
ovatus)
may
also
exhibit
therapy
effect
on
The
aim
this
work
was
evaluate
B.
NAFLD
and
examine
mechanism.
C57BL/6
J
male
mice
were
randomly
divided
into
three
groups:
control
group
(NCD)
that
received
standard
diet,
model
(M)
with
high-fat
high-cholesterol
(HFHC)
M_Bo
fed
HFFC
supplemented
ovatus.
Treatment
could
reduce
body
weight,
prevent
hepatic
steatohepatitis
injury.
Mechanistically,
induced
changes
gut
microbial
diversity
composition,
characterized
by
decreased
Firmicutes/Bacteroidetes
(F/B)
ratio
mice,
lower
abundance
Proteobacteria,
Verrucomicrobiota
at
phylum
level
Ruminococcus_torques_group,
Ruminococcus_gauvreauii_group,
Erysipelatoclostridium
genus
level,
simultaneously
remarkablely
higher
fecal
Lachnospiraceae_NK4A136_group,
norank_f__Oscillospiraceae,
Colidextribacter.
Compared
M
group,
treated
showed
an
markedly
altered
short
chain
acids
(SCFAs),
decline
serum
levels
lipopolysaccharide
(LPS),
CD163,
IL-1β,
TNF-α,
reduced
macrophages
livers.
Additionally,
treatment
caused
downregulation
genes
involved
denovo
lipogenesis
(such
Srebfl,
Acaca,
Scd1,
Fasn),
which
accompanied
upregulation
related
acid
oxidation
Ppara).
In
conclusion,
study
provides
evidence
ameliorate
modulating
gut-liver
axis.
Nutrients,
Journal Year:
2024,
Volume and Issue:
16(14), P. 2232 - 2232
Published: July 11, 2024
Non-alcoholic
fatty
liver
disease
(NAFLD)
is
now
recognized
as
the
most
prevalent
globally.
Pea
albumin
(PA)
has
demonstrated
positive
impacts
on
reducing
obesity
and
improving
glucose
metabolism.
In
this
research,
a
mouse
model
of
NAFLD
induced
by
high-fat
diet
(HFD)
was
employed
to
examine
impact
PA
explore
its
potential
mechanisms.
The
findings
revealed
that
mice
subjected
HFD
developed
pronounced
alterations.
intervention
with
significantly
lowered
serum
TC
26.81%,
TG
43.55%,
LDL-C
57.79%.
It
also
elevated
HDL-C
levels
1.2
fold
reduced
ALT
37.94%
AST
31.21%
in
fed
HFD.
These
changes
contributed
reduction
hepatic
steatosis
lipid
accumulation.
Additionally,
improved
insulin
resistance
inhibited
oxidative
stress
inflammatory
responses.
Mechanistic
studies
alleviated
accumulation
HFD-induced
activating
phosphorylation
AMPKα
ACC,
inhibiting
expression
SREBF1
FASN
reduce
lipogenesis,
increasing
ATGL,
PPARα,
PPARγ
promote
lipolysis
acid
oxidation.
results
indicate
could
serve
dietary
supplement
for
alleviating
NAFLD,
offering
theoretical
foundation
rational
intake
intervention.
Food & Function,
Journal Year:
2023,
Volume and Issue:
14(23), P. 10564 - 10580
Published: Jan. 1, 2023
Osteoporosis,
one
of
the
serious
public
health
problems
worldwide,
can
lead
to
degeneration
bone
structure
and
increased
risk
fractures.
Epigallocatechin
gallate
(EGCG)
is
a
natural
product
with
potential
efficacy
in
inhibiting
loss.
However,
specific
mechanism
remains
unclear.
This
study
first
investigated
role
EGCG
preventing
dexamethasone
(DEX)-induced
osteoporosis
by
regulating
intestinal
microbiota
serum
metabolites.
We
detected
density,
microstructure,
changes
microorganisms
According
our
results,
inhibited
decline
protected
microbial
diversity,
promoted
abundance
beneficial
bacteria
such
as
Prevotellaceae
Ruminococcus,
pathogenic
Peptostreptococcaceae.
There
were
also
significant
metabolites
among
different
treatments.
Differential
mainly
involved
sphingolipid
metabolism
glycerophospholipid
pathways,
especially
ceramide
(d18:0/16:0(2OH)),
phosphatidylserine
(P-20:0/20:4(5Z,8Z,11Z,14Z)),
(18:2(9Z,12Z)/12:0),
phosphatidylethanolamine
(O-16:0/0:00),
which
after
treatment.
Notably,
most
above
positively
correlated
mineral
BV/TV
Tb·Th,
negatively
Tb·Sp.
In
summary,
prevent
damage,
promote
production
metabolites,
enhance
immune
function.
provides
basis
reference
for
prevention
treatment
osteoporosis,
well
application
maintaining
body
health.
Lipids in Health and Disease,
Journal Year:
2024,
Volume and Issue:
23(1)
Published: Aug. 3, 2024
Despite
centuries
of
traditional
use
silymarin
for
hepatoprotection,
current
randomized
controlled
trial
(RCT)
studies
on
the
effectiveness
in
managing
metabolic
dysfunction-associated
steatotic
liver
disease
(MASLD)
are
limited
and
inconclusive,
particularly
when
it
is
administered
alone.
The
low
bioavailability
highlights
possible
influence
gut
microbiota
silymarin;
however,
no
human
have
investigated
this
aspect.
To
determine
potential
efficacy
improving
MASLD
indicators
to
investigate
underlying
mechanisms
related
microbiota.
In
24-week
randomized,
double-blind,
placebo-controlled
trial,
83
patients
with
were
either
placebo
(n
=
41)
or
(103.2
mg/d,
n
42).
At
0,
12,
24
weeks,
stiffness
hepatic
steatosis
assessed
using
FibroScan,
blood
samples
gathered
biochemical
detection,
while
faecal
collected
at
0
weeks
16S
rRNA
sequencing.
Silymarin
supplementation
significantly
reduced
(LSM,
-0.21
±
0.17
vs.
0.41
0.17,
P
0.015)
serum
levels
γ-glutamyl
transpeptidase
(GGT,
-8.21
3.01
1.23
3.16,
0.042)
ApoB
(-0.02
0.03
0.07
0.03,
0.023)
but
had
significant
effect
attenuation
parameter
(CAP),
other
(aminotransferases,
total
bilirubin,
glucose
lipid
parameters,
hsCRP,
SOD,
UA),
physical
measurements
(DBP,
SBP,
BMI,
WHR,
BF%,
BMR),
APRI
FIB-4
indices.
Gut
analysis
revealed
increased
species
diversity
enrichment
Oscillospiraceae
group.
These
findings
suggest
that
could
improve
patients,
possibly
by
modulating
was
registered
Chinese
Clinical
Trial
Registry
(ChiCTR2200059043).